Baiya Phytopharm Co., Ltd.

Startup

Baiya Phytopharm, founded in 2018 as a spin-off from Chulalongkorn University, was co-founded by Waranyoo Phoolcharoen, PhD, an expert in plant-produced proteins, and Suthira Taychakhoonavudh, PhD, an expert in health economics. The company focuses on creating impactful biopharmaceutical solutions through its proprietary BaiyaPharming™ plant-based technology to produce recombinant therapeutic proteins. Its strategic goals include building a strong product pipeline to address unmet medical needs in oncology and non-oncology, such as brain metastases, Respiratory Syncytial Virus (RSV) infection, and asthma, offering CDMO/CRO services via MP Solution, and commercializing products in industries like alternative meats, cosmetics, and gene therapy through BGF Plantrix. Baiya Phytopharm's production facility became the first cGMP-certified plant-based technology facility in Asia. Within 40 months of its founding, the company became a clinical-stage biopharmaceutical firm, with its candidate molecule entering a first-in-human trial in 2021, making it one of the fastest-growing biotech companies in the region.

website